Roche notches fresh win amid crowd of immunotherapy cocktails – Reuters
Reuters |
Roche notches fresh win amid crowd of immunotherapy cocktails
Reuters Still, Roche has an uphill fight to establish Tecentriq as a go-to immunotherapy amid a pack of immunotherapy combinations from rivals that have also scored recent trial wins. Bristol reported on Monday that Opdivo and Yervoy boosted life expectancy in … |
